CN106174470A - 冬虫夏草胶囊配方及其制备方法 - Google Patents
冬虫夏草胶囊配方及其制备方法 Download PDFInfo
- Publication number
- CN106174470A CN106174470A CN201610505236.XA CN201610505236A CN106174470A CN 106174470 A CN106174470 A CN 106174470A CN 201610505236 A CN201610505236 A CN 201610505236A CN 106174470 A CN106174470 A CN 106174470A
- Authority
- CN
- China
- Prior art keywords
- capsule
- caterpillar fungus
- chinese caterpillar
- preparation
- ganoderma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002775 capsule Substances 0.000 title claims abstract description 38
- 241000233866 Fungi Species 0.000 title claims abstract description 31
- 240000001307 Myosotis scorpioides Species 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title claims abstract description 22
- 238000009472 formulation Methods 0.000 title abstract description 4
- 241000190633 Cordyceps Species 0.000 claims abstract description 29
- 241000222336 Ganoderma Species 0.000 claims abstract description 27
- 102000004190 Enzymes Human genes 0.000 claims abstract description 24
- 108090000790 Enzymes Proteins 0.000 claims abstract description 24
- 241000169546 Lycium ruthenicum Species 0.000 claims abstract description 24
- 210000003899 penis Anatomy 0.000 claims abstract description 24
- 210000001550 testis Anatomy 0.000 claims abstract description 24
- 238000000034 method Methods 0.000 claims abstract description 17
- 239000002245 particle Substances 0.000 claims abstract description 14
- 230000008569 process Effects 0.000 claims abstract description 14
- 239000008187 granular material Substances 0.000 claims abstract description 7
- 238000001035 drying Methods 0.000 claims abstract description 5
- 238000004140 cleaning Methods 0.000 claims abstract description 3
- 239000000203 mixture Substances 0.000 claims description 7
- 238000010298 pulverizing process Methods 0.000 claims description 5
- 238000004108 freeze drying Methods 0.000 claims description 4
- 238000004137 mechanical activation Methods 0.000 claims description 4
- 230000036541 health Effects 0.000 abstract description 7
- 239000012567 medical material Substances 0.000 abstract description 7
- 238000005516 engineering process Methods 0.000 abstract description 3
- 230000000694 effects Effects 0.000 description 14
- 210000004369 blood Anatomy 0.000 description 13
- 239000008280 blood Substances 0.000 description 13
- 210000003734 kidney Anatomy 0.000 description 8
- 239000003814 drug Substances 0.000 description 5
- 230000007812 deficiency Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 206010016256 fatigue Diseases 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 230000000259 anti-tumor effect Effects 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 238000007710 freezing Methods 0.000 description 3
- 230000008014 freezing Effects 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 241001018099 Alloteropsis Species 0.000 description 2
- 235000017898 Digitaria ciliaris Nutrition 0.000 description 2
- 108091005804 Peptidases Proteins 0.000 description 2
- 239000004365 Protease Substances 0.000 description 2
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 230000000975 bioactive effect Effects 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 210000003127 knee Anatomy 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 230000009467 reduction Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 239000011800 void material Substances 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 241000628997 Flos Species 0.000 description 1
- 240000008397 Ganoderma lucidum Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010018473 Glycosuria Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 206010034568 Peripheral coldness Diseases 0.000 description 1
- 208000035755 Psychosomatic disease Diseases 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000003064 anti-oxidating effect Effects 0.000 description 1
- 230000002180 anti-stress Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- -1 has antitumor Substances 0.000 description 1
- 230000002607 hemopoietic effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 230000008558 metabolic pathway by substance Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 229940126532 prescription medicine Drugs 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/81—Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
- A61K36/815—Lycium (desert-thorn)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明涉及保健品技术领域,具体地说,涉及一种冬虫夏草胶囊配方及其制备方法。其中,配方包括冬虫夏草、灵芝、西洋参、鹿茸、鹿肾和黑枸杞。制备方法包括以下步骤:(1)取各种药材,分别洗净后干燥;(2)将经步骤(1)处理得到的各组分分别粉碎至粒径为0.5~1.5mm;(3)将经步骤(2)处理得到的各组分分别粉碎至粒径为1~150μm;(4)将经步骤(3)处理得到的各组分与活性酶按一定比例混合后,制粒,并低温干燥后整粒装入胶囊内。本发明易于吸收,使用范围广。
Description
技术领域
本发明涉及保健品技术领域,具体地说,涉及一种冬虫夏草胶囊配方及其制备方法。
背景技术
“亚健康”本身就是一种整体功能失调的表现,处于亚健康状态的人,虽然没有明确的疾病,但却出现精神活力和适应能力下降等症状,如果这种状态不能得到及时的纠正,非常容易引起心身疾病。“亚健康”即中医上讲的“未病”、“欲病”,不是可见的大病,按中医观点而论是身体已经出现了阴阳、气血、脏腑营卫的不平衡状态。根据中医“虚则辅之、实则泻之、热则寒之、寒则热之”的原则,需通过进补来调整虚实,并需依照个人的体质和病症辨证进补,使机体的气血阴阳达到新的平衡,恢复健康。
“配伍”是按照身体特征和药性特点,有选择地将两味以上药物配合同用,以“君臣佐使”为原则,协调整体、滋补调养、降毒增效,这也是滋补养生的根本。未经配伍的单方药村虽然名贵,但滋补调养有限,只有经合理组方才能克服单方的局限,令其性味平和、温凉互济、五脏并调,适宜长期滋补养生。
冬虫夏草作为一种名贵的滋补药材,其在单独进食时,并不能发挥出其最大药性,且单独使用时,适用人群也有限。通过配伍,能够克服以上弊端,但是,现有技术中缺少一种效果较佳的冬虫夏草配方。
发明内容
为了能够克服现有技术的某种或某些缺陷,本发明提供了一种冬虫夏草胶囊配方。
根据本发明的冬虫夏草胶囊配方,其包括:冬虫夏草、灵芝、西洋参、鹿茸、鹿肾和黑枸杞。
作为优选,还包括藏红花。
作为优选,还包括活性酶。
作为优选,各组分的重量百分比分别为,冬虫夏草20%-30%,灵芝10%-15%,西洋参10%-15%,鹿茸10%-15%,鹿肾10%-15%,黑枸杞5%-10%,藏红花5%-10%,活性酶10%。
本发明的冬虫夏草胶囊配方中各成分分析如下,
冬虫夏草平补阴阳的独特功效,使它不仅仅具有良好的保健作用,保持身体的阴阳平衡,从整体上起到补虚强壮的作用。而且,冬虫夏草对免疫系统具有双向调节作用,有良好的抗肿瘤作用,能够有效改善机体的物质代谢;冬虫夏草还具有明显的抗自由基、抗氧化作用,能够调节内分泌功能、滋阴补肾壮阳,能够抗衰老,增强记忆力,抗缺氧,抗疲劳,提高运动能力等。研究表明,冬虫夏草对机体各大重要的器官系统如呼吸系统、肝脏、肾脏、血液系统、循环系统、中枢神经系统等均有良好的调节与治疗作用。
鹿茸、鹿肾具有壮元阳,补气血,益精髓,强筋骨之功效。能够用于肾阳不足,精血虚亏,头晕耳鸣,腰膝酸软,四肢冷,神疲体倦;肝肾不足,筋骨痿软。
西洋参性甘、微苦,凉,归心、肺、肾经。
补气养阴,清热生津。用于气虚阴亏,内热,咳喘痰血,虚热烦倦,消渴,口燥咽干。西洋参有抗疲劳、抗氧化、抗应激、抑制血小板聚集、降低血液凝固性的作用,另外,对糖尿病患者还有调节血糖的作用。
灵芝为多孔菌科真菌赤芝或紫芝的干燥子实体。灵芝性干、平,归心、肺、肾经。具有补气安神,止咳平喘之功效;常用于心神不宁,失眠心悸,肺虚咳嗽,虚劳短气及不思饮食等。据现代研究表明灵芝主要以多糖为主,具有抗肿瘤,降血糖,促进核酸蛋白质合成代谢,具有改善造血功能,增强免疫等作用。
藏红花为鸢尾科植物番红花的干燥柱头,具有活血祛瘀,散郁开结,凉血解毒的功效。用于治疗忧思郁结,忧郁痞闷,惊悸发狂,瘀血作痛,跌打损伤等。近年来研究还表明藏红花具有一定的抗肿瘤效果。
黑枸杞是我国传统的药食两用的名贵中药材,其味干、性平,具有滋补肝肾、益精明目,适用于腰膝酸软、头晕目眩、两眼昏花等症状。
活性酶能够采用生物活性酶,生物活性酶主要由发酵而成,不但富含对人体有益的多种活性酶、多糖、蛋白质、氨基酸、维生素等营养物质,更加速催化冬虫夏草等中药材功能因子的功效成分,促进体内的新陈代谢,其具有纯生物、无毒无害,加速人体吸收的特点。
本发明将冬虫夏草、活性酶、灵芝、西洋参、鹿茸、鹿肾、黑枸杞和藏红花组方,能够较佳地改善机体亚健康状态,固本培元,补肺益肾、温肾填精、延缓衰老、提高机体免疫能力。
本发明的冬虫夏草胶囊,阴阳平和、调理肾阳,通过将冬虫夏草配伍其他药材使用,几种成分有效配伍,协同发挥功效,相得益彰。使得机体气血阴阳达到新的平衡,恢复健康。俗话说就是打好底子,精力自然充沛、体力自然增强,不是西药是外在的药理作用,完全是自身的生理机能的反应,是真正的恢复。
为了能够克服现有技术的某种或某些缺陷,本发明还提供了一种冬虫夏草胶囊的制备方法。
根据本发明的冬虫夏草胶囊的制备方法,其包括以下步骤:
(1)取冬虫夏草、灵芝、西洋参、鹿茸、鹿肾和黑枸杞,分别洗净后干燥;
(2)将经步骤(1)处理得到的各组分分别粉碎至粒径为0.5~1.5mm;
(3)将经步骤(2)处理得到的各组分分别粉碎至粒径为1~150μm;
(4)将经步骤(3)处理得到的各组分按一定比例混合后,制粒,并低温干燥后整粒装入胶囊内。
本发明的冬虫夏草胶囊的制备方法中,能够首先将各成分进行干燥,并使得干燥后的水分低于9%,从而使得各组分的有效成分能够得到较佳地发挥。另外,能够将干燥后的各种药材首先粗粉碎再进行细粉碎,从而能够较佳地保持各药材中的有效成分。
作为优选,步骤(1)中的组分中还包括藏红花。
作为优选,步骤(4)中,还混合有活性酶。
本发明中,能够将各种药材的细粉与活性酶进行混合,从而使得通过本发明的方法制备的冬虫夏草胶囊能够较佳地被人体吸收。其中,活性酶能够采用例如活性蛋白酶。
作为优选,步骤(4)中,各组分的重量百分比分别为,冬虫夏草20%-30%,灵芝10%-15%,西洋参10%-15%,鹿茸10%-15%,鹿肾10%-15%,黑枸杞5%-10%,藏红花5%-10%,活性酶10%。
作为优选,步骤(1)中,采用真空冷冻干燥。
本发明中,能够采用真空冷冻干燥的方法对各药材进行干燥,从而能够较佳地保持各药材中的有效成分。
作为优选,步骤(2)中,粉碎方式采用机械粉碎、气流粉碎、振动粉碎中的一种或多种。
具体实施方式
为进一步了解本发明的内容,结合实施例对本发明作详细描述。应当理解的是,实施例仅仅是对本发明进行解释而并非限定。
实施例1
本实施例提供了一种冬虫夏草胶囊配方以及其制备方法,其由冬虫夏草、灵芝、西洋参、鹿茸、鹿肾和黑枸杞组成。其中,各组分的重量百分比分别为:冬虫夏草30%、灵芝15%、西洋参15%、鹿茸15%、鹿肾15%、黑枸杞10%。
本实施例中的冬虫夏草胶囊的制备方法,包括以下步骤:
(1)取冬虫夏草、灵芝、西洋参、鹿茸、鹿肾和黑枸杞,分别洗净后真空冷冻干燥,使得每个组分的水分含量低于9%;
(2)将经步骤(1)处理得到的各组分分别粉碎至粒径在0.5~1.5mm范围内;
(3)将经步骤(2)处理得到的各组分经机械粉碎或气流粉碎或振动粉碎分别粉碎至粒径在1~150μm范围内;
(4)将经步骤(3)处理得到的各组分按上述比例混合后,制粒,并低温干燥后整粒装入胶囊内。
实施例2
本实施例也提供了一种冬虫夏草胶囊配方以及其制备方法,其由冬虫夏草、灵芝、西洋参、鹿茸、鹿肾、黑枸杞和藏红花组成,其中,各组分的重量百分比分别为:冬虫夏草25%、灵芝20%、西洋参15%、鹿茸10%、鹿肾10%、黑枸杞10%、藏红花10%。
本实施例中的冬虫夏草胶囊的制备方法,包括以下步骤:
(1)取冬虫夏草、灵芝、西洋参、鹿茸、鹿肾、黑枸杞和藏红花,分别洗净后真空冷冻干燥,使得每个组分的水分含量低于9%;
(2)将经步骤(1)处理得到的各组分分别粉碎至粒径在0.5~1.5mm范围内;
(3)将经步骤(2)处理得到的各组分先机械粉碎再气流粉碎分别粉碎至粒径在1~150μm范围内;
(4)将经步骤(3)处理得到的各组分按上述比例混合后,制粒,并低温干燥后整粒装入胶囊内。
实施例3
本实施例也提供了一种冬虫夏草胶囊配方以及其制备方法,其由冬虫夏草、灵芝、西洋参、鹿茸、鹿肾、黑枸杞、藏红花和活性酶组成,其中,各组分的重量百分比分别为:冬虫夏草20%、活性酶10%、灵芝10%、西洋参10%、鹿茸15%、鹿肾15%、黑枸杞10%、和藏红花10%。
本实施例中的冬虫夏草胶囊的制备方法,包括以下步骤:
(1)取冬虫夏草、灵芝、西洋参、鹿茸、鹿肾、黑枸杞和藏红花,分别洗净后真空冷冻干燥,使得每个组分的水分含量低于9%;
(2)将经步骤(1)处理得到的各组分经气流粉碎分别粉碎至粒径在0.5~1.5mm范围内;
(3)将经步骤(2)处理得到的各组分分别粉碎至粒径在1~150μm范围内;
(4)将经步骤(3)处理得到的各组分与活性酶按上述比例混合后,制粒,并低温干燥后整粒装入胶囊内。
实施例4
本实施例也提供了一种冬虫夏草胶囊配方以及其制备方法,其由冬虫夏草、灵芝、西洋参、鹿茸、鹿肾、黑枸杞、藏红花和活性酶组成,其中,各组分的重量百分比分别为:冬虫夏草30%、活性酶10%、灵芝15%、西洋参15%、鹿茸10%、鹿肾10%、黑枸杞5%、和藏红花5%。
本实施例中的冬虫夏草胶囊的制备方法,包括以下步骤:
(1)取冬虫夏草、灵芝、西洋参、鹿茸、鹿肾、黑枸杞和藏红花,分别洗净后真空冷冻干燥,使得每个组分的水分含量低于9%;
(2)将经步骤(1)处理得到的各组分先振动粉碎再气流粉碎分别粉碎至粒径在0.5~1.5mm范围内;
(3)将经步骤(2)处理得到的各组分分别粉碎至粒径在1~150μm范围内;
(4)将经步骤(3)处理得到的各组分与活性酶按上述比例混合后,制粒,并低温干燥后整粒装入胶囊内。
实施例5
本实施例也提供了一种冬虫夏草胶囊配方,其与实施例4的不同之处在于:各组分的重量百分比分别为,冬虫夏草25%,灵芝13%,西洋参12%,鹿茸11%,鹿肾14%,黑枸杞8%,藏红花7%,活性酶10%。
本实施例中,活性酶采用活性蛋白酶。
以上示意性地对本发明及其实施方式进行了描述,该描述没有限制性。所以,如果本领域的普通技术人员受其启示,在不脱离本发明创造宗旨的情况下,不经创造性地设计出与该技术方案相似的方案及实施例,均应属于本发明的保护范围。
Claims (10)
1.冬虫夏草胶囊配方,其特征在于:包括冬虫夏草、灵芝、西洋参、鹿茸、鹿肾和黑枸杞。
2.根据权利要求2所述的冬虫夏草胶囊配方,其特征在于:还包括藏红花。
3.根据权利要求2所述的冬虫夏草胶囊配方,其特征在于:还包括活性酶。
4.根据权利要求3所述的冬虫夏草胶囊配方,其特征在于:各组分的重量百分比分别为,冬虫夏草20%-30%,灵芝10%-15%,西洋参10%-15%,鹿茸10%-15%,鹿肾10%-15%,黑枸杞5%-10%,藏红花5%-10%,活性酶10%。
5.冬虫夏草胶囊的制备方法,其包括以下步骤:
(1)取冬虫夏草、灵芝、西洋参、鹿茸、鹿肾和黑枸杞,分别洗净后干燥;
(2)将经步骤(1)处理得到的各组分分别粉碎至粒径为0.5~1.5mm;
(3)将经步骤(2)处理得到的各组分分别粉碎至粒径为1~150μm;
(4)将经步骤(3)处理得到的各组分按一定比例混合后,制粒,并低温干燥后整粒装入胶囊内。
6.根据权利要求5中所述的冬虫夏草胶囊的制备方法,其特征在于:步骤(1)中的组分中还包括藏红花。
7.根据权利要求6中所述的冬虫夏草胶囊的制备方法,其特征在于:步骤(4)中,还混合有活性酶。
8.根据权利要求7中所述的冬虫夏草胶囊的制备方法,其特征在于:步骤(4)中,各组分的重量百分比分别为,冬虫夏草20%-30%,灵芝10%-15%,西洋参10%-15%,鹿茸10%-15%,鹿肾10%-15%,黑枸杞5%-10%,藏红花5%-10%,活性酶10%。
9.根据权利要求5~8中所述的冬虫夏草胶囊的制备方法,其特征在于:步骤(1)中,采用真空冷冻干燥。
10.根据权利要求9中所述的冬虫夏草胶囊的制备方法,其特征在于:步骤(2)中,粉碎方式采用机械粉碎、气流粉碎、振动粉碎中的一种或多种。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610505236.XA CN106174470A (zh) | 2016-06-27 | 2016-06-27 | 冬虫夏草胶囊配方及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610505236.XA CN106174470A (zh) | 2016-06-27 | 2016-06-27 | 冬虫夏草胶囊配方及其制备方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106174470A true CN106174470A (zh) | 2016-12-07 |
Family
ID=57463945
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610505236.XA Pending CN106174470A (zh) | 2016-06-27 | 2016-06-27 | 冬虫夏草胶囊配方及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106174470A (zh) |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101417127A (zh) * | 2008-09-11 | 2009-04-29 | 西藏剑圣生物药物制品开发有限公司 | 女性补肾养颜胶囊 |
CN103432208A (zh) * | 2013-07-29 | 2013-12-11 | 北京阜康仁生物制药科技有限公司 | 一种含有冬虫夏草的药用组合物 |
TWM473935U (zh) * | 2013-11-28 | 2014-03-11 | Ta Chiang Internat Co Ltd | 具提神增強體力之含馬卡、人蔘、蟲草精華之微粒結構 |
CN103961380A (zh) * | 2014-05-28 | 2014-08-06 | 郭海涛 | 一种冬虫夏草片及其制备方法 |
-
2016
- 2016-06-27 CN CN201610505236.XA patent/CN106174470A/zh active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101417127A (zh) * | 2008-09-11 | 2009-04-29 | 西藏剑圣生物药物制品开发有限公司 | 女性补肾养颜胶囊 |
CN103432208A (zh) * | 2013-07-29 | 2013-12-11 | 北京阜康仁生物制药科技有限公司 | 一种含有冬虫夏草的药用组合物 |
TWM473935U (zh) * | 2013-11-28 | 2014-03-11 | Ta Chiang Internat Co Ltd | 具提神增強體力之含馬卡、人蔘、蟲草精華之微粒結構 |
CN103961380A (zh) * | 2014-05-28 | 2014-08-06 | 郭海涛 | 一种冬虫夏草片及其制备方法 |
Non-Patent Citations (2)
Title |
---|
蔡向红: "《家庭用药宜忌随身查》", 30 April 2015, 天津科学技术出版社 * |
郜凤香: "《中药制剂技术》", 31 August 2015, 郑州大学出版社 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100335107C (zh) | 一种保健药酒 | |
CN103627610B (zh) | 一种复方红景天酒的制备方法 | |
CN104840722A (zh) | 一种功能性养生珍品的组合物及其制备方法、应用方法 | |
CN106509881A (zh) | 一种草本酵素及其制备方法 | |
CN106578801A (zh) | 一种具有降糖作用的综合酵素粉及其制备方法 | |
CN107319086A (zh) | 一种枸杞金丝皇菊压片糖果及其制备方法 | |
CN106261447A (zh) | 一种护肝、缓解酒后不适的固体饮料及其制备方法 | |
CN110075266A (zh) | 一种养肾固肾补气血的配方及制备方法 | |
CN101884783A (zh) | 一种含有麦麸多肽的抗疲劳中药及其制备方法 | |
CN101417127A (zh) | 女性补肾养颜胶囊 | |
CN102861235B (zh) | 一种纯中药养生制剂 | |
CN103082240B (zh) | 一种胡萝卜参的加工方法 | |
CN106581292A (zh) | 龙族膏方及其制备方法 | |
CN107156820A (zh) | 全面调理女性产后受损体质的营养食品及其制备方法 | |
CN105920269A (zh) | 一种女性保健药酒 | |
CN101912523A (zh) | 一种治疗小儿缺铁性贫血症的中药制剂 | |
CN101564431B (zh) | 一种强身抗疲劳抗衰老的中药制剂及其制作方法 | |
CN102669340A (zh) | 一种改善营养性贫血的食品养血茶冲剂 | |
CN107080781A (zh) | 一种儿童补益壮骨调理增高的外用复方精油组合物 | |
CN106038743A (zh) | 一种降血压冲剂、制备方法及其应用 | |
CN106579384A (zh) | 一种具有分解脂肪作用的综合酵素粉及其制备方法 | |
CN106174470A (zh) | 冬虫夏草胶囊配方及其制备方法 | |
CN102988747B (zh) | 一种三刺降三高的冲剂及其制备方法 | |
CN1323598A (zh) | 抗疲劳胶囊 | |
CN111357984A (zh) | 一种润肺滋肾的营养组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20161207 |
|
RJ01 | Rejection of invention patent application after publication |